Lactase
发表于 2025-3-21 16:42:44
书目名称Hormone Therapy and Castration Resistance of Prostate Cancer影响因子(影响力)<br> http://figure.impactfactor.cn/if/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer影响因子(影响力)学科排名<br> http://figure.impactfactor.cn/ifr/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer网络公开度<br> http://figure.impactfactor.cn/at/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer网络公开度学科排名<br> http://figure.impactfactor.cn/atr/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer被引频次<br> http://figure.impactfactor.cn/tc/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer被引频次学科排名<br> http://figure.impactfactor.cn/tcr/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer年度引用<br> http://figure.impactfactor.cn/ii/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer年度引用学科排名<br> http://figure.impactfactor.cn/iir/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer读者反馈<br> http://figure.impactfactor.cn/5y/?ISSN=BK0428319<br><br> <br><br>书目名称Hormone Therapy and Castration Resistance of Prostate Cancer读者反馈学科排名<br> http://figure.impactfactor.cn/5yr/?ISSN=BK0428319<br><br> <br><br>
不如屎壳郎
发表于 2025-3-21 22:35:47
http://reply.papertrans.cn/43/4284/428319/428319_2.png
食品室
发表于 2025-3-22 01:26:57
http://reply.papertrans.cn/43/4284/428319/428319_3.png
Ancestor
发表于 2025-3-22 08:03:08
Bone Scan Index as a Biomarker of Bone Metastasis,ENAVI in Japan), and its advantages and disadvantages. The BSI could serve as a reliable marker of disease progression and treatment effects as well as a prognostic indicator. The index can also reflect the effects of new drugs and internal radiation therapy on bone metastasis and help in its management.
backdrop
发表于 2025-3-22 12:23:10
Introduction,e situation has gradually changed toward earlier and longer use of hormone therapy. The malignancy will finally form castration-resistant prostate cancer (CRPC) despite the lack of testicular androgen.
strain
发表于 2025-3-22 13:54:58
Patient-Derived Xenografts for Research on Hormonal Therapy of Prostate Cancer,t the molecular diversity of human prostate cancer. Herein, we will introduce representative prostate cancer PDX models, including our established models, and discuss potential usefulness together with future perspectives.
现晕光
发表于 2025-3-22 18:29:09
Controversies on Combined Androgen Blockade for Prostate Cancer,inical trials to examine superiority of complete androgen blockade using adrenal androgen synthesis inhibitor or more powerful new antiandrogen instead of CAB as an initial treatment is ongoing for advanced prostate cancer.
Nausea
发表于 2025-3-22 23:51:00
http://reply.papertrans.cn/43/4284/428319/428319_8.png
合群
发表于 2025-3-23 03:26:06
http://reply.papertrans.cn/43/4284/428319/428319_9.png
cravat
发表于 2025-3-23 08:32:24
Adrenal Androgen in Prostate Cancer,after ADT that serves as the substrate for the production of more active androgens by steroidal metabolism enzymes. Production of active androgens participates in cancer proliferation to become castration-resistant Pca (CRPC).